Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of Risk Prediction Equations for Incident Chronic Kidney Disease.
Nelson RG, Grams ME, Ballew SH, Sang Y, Azizi F, Chadban SJ, Chaker L, Dunning SC, Fox C, Hirakawa Y, Iseki K, Ix J, Jafar TH, Köttgen A, Naimark DMJ, Ohkubo T, Prescott GJ, Rebholz CM, Sabanayagam C, Sairenchi T, Schöttker B, Shibagaki Y, Tonelli M, Zhang L, Gansevoort RT, Matsushita K, Woodward M, Coresh J, Shalev V; CKD Prognosis Consortium. Nelson RG, et al. Among authors: tonelli m. JAMA. 2019 Dec 3;322(21):2104-2114. doi: 10.1001/jama.2019.17379. JAMA. 2019. PMID: 31703124 Free PMC article.
Effect of pravastatin in people with diabetes and chronic kidney disease.
Tonelli M, Keech A, Shepherd J, Sacks F, Tonkin A, Packard C, Pfeffer M, Simes J, Isles C, Furberg C, West M, Craven T, Curhan G. Tonelli M, et al. J Am Soc Nephrol. 2005 Dec;16(12):3748-54. doi: 10.1681/ASN.2005070779. Epub 2005 Oct 26. J Am Soc Nephrol. 2005. PMID: 16251235 Clinical Trial.
Chronic kidney disease and mortality risk: a systematic review.
Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX. Tonelli M, et al. J Am Soc Nephrol. 2006 Jul;17(7):2034-47. doi: 10.1681/ASN.2005101085. Epub 2006 May 31. J Am Soc Nephrol. 2006. PMID: 16738019 Review.
Prophylaxis strategies for contrast-induced nephropathy.
Pannu N, Wiebe N, Tonelli M; Alberta Kidney Disease Network. Pannu N, et al. Among authors: tonelli m. JAMA. 2006 Jun 21;295(23):2765-79. doi: 10.1001/jama.295.23.2765. JAMA. 2006. PMID: 16788132 Review.
Kidney disease and cardiovascular risk.
Tonelli M, Pfeffer MA. Tonelli M, et al. Annu Rev Med. 2007;58:123-39. doi: 10.1146/annurev.med.58.071105.111123. Annu Rev Med. 2007. PMID: 17081079 Review.
NSAID use and progression of chronic kidney disease.
Gooch K, Culleton BF, Manns BJ, Zhang J, Alfonso H, Tonelli M, Frank C, Klarenbach S, Hemmelgarn BR. Gooch K, et al. Among authors: tonelli m. Am J Med. 2007 Mar;120(3):280.e1-7. doi: 10.1016/j.amjmed.2006.02.015. Am J Med. 2007. PMID: 17349452
Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial.
Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, Tonelli M, Donnelly S, Friedrich MG, Kumar A, Mahallati H, Hemmelgarn BR, Manns BJ. Culleton BF, et al. Among authors: tonelli m. JAMA. 2007 Sep 19;298(11):1291-9. doi: 10.1001/jama.298.11.1291. JAMA. 2007. PMID: 17878421 Clinical Trial.
Prevalence of chronic kidney disease and survival among aboriginal people.
Gao S, Manns BJ, Culleton BF, Tonelli M, Quan H, Crowshoe L, Ghali WA, Svenson LW, Hemmelgarn BR; Alberta Kidney Disease Network. Gao S, et al. Among authors: tonelli m. J Am Soc Nephrol. 2007 Nov;18(11):2953-9. doi: 10.1681/ASN.2007030360. Epub 2007 Oct 17. J Am Soc Nephrol. 2007. PMID: 17942955
1,317 results